Cargando…
Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
Of patients being treated by radiotherapy for cancer, a small proportion develop marked long-term radiation damage. It is believed that this is due, at least in part, to intrinsic individual differences in radiosensitivity, but the underlying mechanism is unknown. Individuals affected by the recessi...
Autores principales: | Shayeghi, M., Seal, S., Regan, J., Collins, N., Barfoot, R., Rahman, N., Ashton, A., Moohan, M., Wooster, R., Owen, R., Bliss, J. M., Stratton, M. R., Yarnold, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063134/ https://www.ncbi.nlm.nih.gov/pubmed/9764584 |
Ejemplares similares
-
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022) -
Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021) -
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia
por: Byrd, P J, et al.
Publicado: (2012) -
Dysarthria in children and adults with ataxia telangiectasia
por: Veenhuis, Stefanie J G, et al.
Publicado: (2021) -
Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015)